CRMD FY 2025 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$312M+617.0% YoY

Gross Profit

$276M88.5% margin

Operating Income

$150M48.2% margin

Net Income

$163M52.3% margin

EPS (Diluted)

$2.04

Cash Flow

Operating Cash Flow

$175M

Free Cash Flow

$175M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$826M

Total Liabilities

$421M

Stockholders' Equity

$405M

Cash & Equivalents

$145M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$312M	$43M	+617.0%
Gross Profit	$276M	$40M	+584.6%
Operating Income	$150M	-$22M	+771.6%
Net Income	$163M	-$18M	+1009.4%